Hologic Financial Statements (HOLX)
|
|
Report date
|
|
|
24.09.2022 |
15.11.2022 |
30.09.2023 |
21.11.2023 |
30.09.2024 |
|
04.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
4 863 |
4 863 |
4 030 |
4 030 |
|
|
4 029 |
Operating Income, bln rub |
|
|
1 640 |
1 640 |
668.4 |
668.4 |
|
|
1 001 |
EBITDA, bln rub |
? |
|
1 773 |
2 113 |
1 204 |
1 111 |
|
|
1 327 |
Net profit, bln rub |
? |
|
1 302 |
1 302 |
456.0 |
456.0 |
|
|
737.5 |
|
OCF, bln rub |
? |
|
2 126 |
2 126 |
1 051 |
1 051 |
|
|
1 104 |
CAPEX, bln rub |
? |
|
70.6 |
127.2 |
150.2 |
150.2 |
|
|
115.8 |
FCF, bln rub |
? |
|
2 055 |
1 999 |
901.0 |
901.0 |
|
|
988.2 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
|
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
0 |
|
OPEX, bln rub |
|
|
1 357 |
1 367 |
1 310 |
1 310 |
|
|
1 256 |
Cost of production, bln rub |
|
|
1 865 |
1 865 |
1 959 |
1 959 |
|
|
1 772 |
R&D, bln rub |
|
|
283.4 |
283.4 |
294.3 |
294.3 |
|
|
270.1 |
Interest expenses, bln rub |
|
|
95.1 |
95.1 |
111.1 |
111.1 |
|
|
128.1 |
|
Assets, bln rub |
|
|
9 071 |
9 071 |
9 139 |
9 139 |
9 156 |
|
9 156 |
Net Assets, bln rub |
? |
|
4 876 |
4 876 |
5 017 |
5 017 |
5 130 |
|
5 130 |
Debt, bln rub |
|
|
2 823 |
2 823 |
2 818 |
2 818 |
2 535 |
|
2 535 |
Cash, bln rub |
|
|
2 340 |
2 340 |
2 723 |
2 723 |
2 334 |
|
2 334 |
Net debt, bln rub |
|
|
483.9 |
483.9 |
95.7 |
95.7 |
201.0 |
|
201.0 |
|
Ordinary share price, rub |
|
|
63.0 |
63.0 |
69.4 |
69.4 |
81.5 |
|
66.6 |
Number of ordinary shares, mln |
|
|
251.5 |
251.5 |
246.8 |
246.8 |
|
|
233.8 |
|
Market cap, bln rub |
|
|
15 841 |
15 841 |
17 126 |
17 126 |
0 |
|
15 560 |
EV, bln rub |
? |
|
16 325 |
16 325 |
17 222 |
17 222 |
201 |
|
15 761 |
Book value, bln rub |
|
|
4 876 |
359 |
5 017 |
847 |
5 130 |
|
5 130 |
|
EPS, rub |
? |
|
5.18 |
5.18 |
1.85 |
1.85 |
|
|
3.15 |
FCF/share, rub |
|
|
8.17 |
7.95 |
3.65 |
3.65 |
|
|
4.23 |
BV/share, rub |
|
|
19.4 |
1.43 |
20.3 |
3.43 |
|
|
21.9 |
|
EBITDA margin, % |
? |
|
36.5% |
43.5% |
29.9% |
27.6% |
|
|
32.9% |
Net margin, % |
? |
|
26.8% |
26.8% |
11.3% |
11.3% |
|
|
18.3% |
FCF yield, % |
? |
|
13.0% |
12.6% |
5.26% |
5.26% |
0.00% |
|
6.35% |
ROE, % |
? |
|
26.7% |
26.7% |
9.09% |
9.09% |
0.00% |
|
14.4% |
ROA, % |
? |
|
14.4% |
14.4% |
4.99% |
4.99% |
0.00% |
|
8.05% |
|
P/E |
? |
|
12.2 |
12.2 |
37.6 |
37.6 |
|
|
21.1 |
P/FCF |
|
|
7.71 |
7.93 |
19.0 |
19.0 |
|
|
15.7 |
P/S |
? |
|
3.26 |
3.26 |
4.25 |
4.25 |
|
|
3.86 |
P/BV |
? |
|
3.25 |
44.1 |
3.41 |
20.2 |
0.00 |
|
3.03 |
EV/EBITDA |
? |
|
9.21 |
7.72 |
14.3 |
15.5 |
|
|
11.9 |
Debt/EBITDA |
|
|
0.27 |
0.23 |
0.08 |
0.09 |
|
|
0.15 |
|
R&D/CAPEX, % |
|
|
401.4% |
222.8% |
195.9% |
195.9% |
|
|
233.2% |
|
CAPEX/Revenue, % |
|
|
1.45% |
2.62% |
3.73% |
3.73% |
|
|
2.87% |
|
Hologic shareholders |